Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
4
Added to
11
Trimmed
16
Exited
10
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $9.04B across 91 positions in their Q1 2025 SEC 13F filing (period ending 2025-03-31). The top 10 positions account for 81.8% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | ONCBeiGene, Ltd. | $2.39B | 26.50% | -7.7% |
| 2 | INCYIncyte Corporation | $1.86B | 20.60% | +0.0% |
| 3 | ACADACADIA Pharmaceuticals Inc. | $712.20M | 7.88% | - |
| 4 | MDGLMadrigal Pharmaceuticals, Inc. | $654.04M | 7.24% | - |
| 5 | SMMTSummit Therapeutics Inc. | $471.16M | 5.21% | - |
| 6 | INSMInsmed Incorporated | $410.49M | 4.54% | +7.5% |
| 7 | RYTMRhythm Pharmaceuticals, Inc. | $296.87M | 3.29% | -7.9% |
| 8 | RVMDRevolution Medicines, Inc. | $280.65M | 3.11% | - |
| 9 | KYMRKymera Therapeutics, Inc. | $164.11M | 1.82% | - |
| 10 | ALKSAlkermes plc | $148.04M | 1.64% | +7.2% |
| Stock | Value | Shares |
|---|---|---|
| VRNAVerona Pharma plc | $14.21M | 223,843 |
| RGLSRegulus Therapeutics Inc. | $4.71M | 2,694,044 |
| SIONSionna Therapeutics, Inc. | $4.18M | 400,000 |
| TECXTectonic Therapeutic, Inc. | $1.77M | 100,000 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.